[ABCL] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
02-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 6.28%
YoY- -207.46%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 7,323 9,954 9,179 6,599 10,056 12,192 21,545 -51.32%
PBT -48,187 -42,747 -48,602 -39,276 -38,004 -48,148 -31,412 33.04%
Tax -11,257 -2,137 -1,452 -10,666 -7,476 -8,038 -1,519 280.57%
NP -36,930 -40,610 -47,150 -28,610 -30,528 -40,110 -29,893 15.14%
Tax Rate - - - - - - - -
Total Cost 44,253 50,564 56,329 35,209 40,584 52,302 51,438 -9.55%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -504.30 -407.98 -513.67 -433.55 -303.58 -328.99 -138.75 136.58%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.13 -0.14 -0.16 -0.10 -0.11 -0.14 -0.10 19.13%
EPS Diluted -0.13 -0.14 -0.16 -0.10 -0.11 -0.14 -0.10 19.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.